GGrantIndex
Sort

11,323 grants matching glioblastoma

Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer

$2,278,098
Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA

Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma

$2,277,604
Susan M Chang · University Of California, San Francisco · P01 · FY2021 · CA

Developmental and HyperActive Ras Tumor SPORE

$2,271,783
David W. Clapp · Indiana University Indianapolis · U54 · FY2017 · CA

Gene therapy of cancer

$2,268,631
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Integrative Pathophysiology of Solid Tumors

$2,264,020
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2015 · CA

Cancer as a Complex Adaptive System

$2,257,782
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2016 · CA

SPORE: Targeted Therapies for Glioma

$2,252,175
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2021 · CA

Genetics and Biology of Malignant Glioma

$2,252,010
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

SPORE: Targeted Therapies for Glioma

$2,250,039
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2022 · CA

Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas

$2,245,802
Michael J Brownstein · Myosin Therapeutics Inc. · R44 · FY2025 · CA

COBRE: Center for Computational Biology of Human Disease

$2,244,625
David M Rand · Brown University · P20 · FY2019 · GM

Integrative Pathophysiology of Solid Tumors

$2,243,002
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2012 · CA

GENE THERAPY FOR BRAIN TUMORS

$2,241,721
Massachusetts General Hospital · P01 · FY2004 · CA

Cancer as a Complex Adaptive System

$2,240,338
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2017 · CA

Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma

$2,238,345
Susan M Chang · University Of California, San Francisco · P01 · FY2020 · CA

Integrative Pathophysiology of Solid Tumors

$2,237,643
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2016 · CA

Brain Tumor Clinical and Clinical Research Program

$2,237,606
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2023 · CA

Gene therapy of cancer

$2,237,547
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Gene-engineered adoptive T cell immunotherapy of GBM

$2,237,545
Laura A Johnson · University Of Pennsylvania · DP2 · FY2012 · CA

Molecular Pathogenesis of Neoplasia

$2,235,363
Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Mechanisms Underlying Clearance of Persistent Infections and Tumors

$2,228,983
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Cancer as a Complex Adaptive System

$2,227,365
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA

Increasing the therapeutic index of brain tumor treatment through innovative FLASH radiotherapy

$2,222,254
Charles Limoli · University Of California-Irvine · P01 · FY2022 · CA

Molecular Diagnostics Core Laboratory

$2,218,020
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

Brain Tumor Clinical and Clinical Research Program

$2,214,994
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2022 · CA